Glaxo set for big push into emerging markets

GlaxoSmithKline's new chief executive signalled his intent to launch an expansion drive into the emerging markets yesterday as he revealed his strategic objectives for the first time and announced a "transformational" partnership with a South African drugs company.

Andrew Witty, who took over from Jean-Pierre Garnier at the end of May, also admitted that the pharmaceuticals industry faced a "challenging" future as companies are set to lose billions from expired patents and the costs of research and development continue to soar. He issued a rallying cry that the industry should "seize the initiative".

Glaxo has signed a licensing and supply agreement with Aspen, a South African pharmaceuticals group, and its joint venture partner Strides Arcolab – a deal it described as "a transformational agreement to significantly extend its pharmaceutical portfolio in emerging markets".

The group added: "This signals a significant new strategy from GlaxoSmithKline to accelerate sales growth in emerging markets." Emerging markets are forecast to grow by three times the rate of the West, and will account for 40 per cent of growth in global pharmaceutical market by 2020, Glaxo added.

One of Mr Witty's first moves as chief executive was to create a new emerging markets division and appoint Abbas Hussain as president last month.

The group added it had already prioritised investments in the regions and had bulked up its regulatory expertise as a result. Speaking on the day of his first quarterly results presentation, Mr Witty said the announcement demonstrated the company's focus "where growth in both population and economic prosperity is leading to increased demand for branded pharmaceuticals".

Mr Witty also laid out his strategic priorities for Glaxo's business to investors yesterday. He plans to simplify the group's operating structure, diversify the business and put more emphasis on "products of value".

He said: "In the next few years the pharmaceutical industry will face immense challenges as an unprecedented number of products lose patent protection. This will be set against a backdrop of payers searching for ever more cost-effective healthcare and escalating patient demand for new and better medicines."

One analyst said companies would lose $200bn (£100bn) from patent expiry over the next five years and only half of that would be replaced by drugs coming through the current clinical pipeline. Mr Witty said the future of healthcare was "challenging" but held "significant opportunity".

The group is set to target growing areas including vaccines and consumer healthcare products as well as new growth areas such as biopharmaceuticals. "These businesses offer significant growth opportunities to GlaxoSmithKline through new products and geographic expansion," Mr Witty said.

James Millett, an analyst at Cazenove, said: "The strategic review from the new chief executive should give some comfort to GlaxoSmithKline investors." However, he added that there was a "lack of well-defined targets being disclosed".

Glaxo yesterday beat analyst expectations as it announced that turnover in the second quarter was up 4 per cent to £5.8bn driven by stronger performance in the vaccines division.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Account Manager / Membership Manager

£35 - 38k + Benefits & Bonus: Guru Careers: We are seeking an Account Manager ...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: At SThree, we like to be differe...

Guru Careers: Associate Director

£50 - 80k: Guru Careers: We are seeking an Associate Director for the Markets ...

Guru Careers: Associate Director / Director of Sound Practices

£60 - 100k: Guru Careers: Our client is looking for an Associate Director of S...

Day In a Page

Giants Club: After wholesale butchery of Idi Amin's regime, Uganda’s giants flourish once again

Uganda's giants are flourishing once again

After the wholesale butchery of Idi Amin's regime, elephant populations are finally recovering
The London: After 350 years, the riddle of Britain's exploding fleet is finally solved

After 350 years, the riddle of Britain's exploding fleet is finally solved

Archaeologists will recover a crucial item from the wreck of the London which could help shed more light on what happened in the vessel's final seconds
Airbus has patented a jet that could fly from London to New York in one hour

Airbus has patented a jet that could fly from London to New York in one hour

The invention involves turbojets and ramjets - a type of jet engine - and a rocket motor
10 best sun creams for kids

10 best sun creams for kids

Protect delicate and sensitive skin with products specially formulated for little ones
Tate Sensorium: New exhibition at Tate Britain invites art lovers to taste, smell and hear art

Tate Sensorium

New exhibition at Tate Britain invites art lovers to taste, smell and hear art
Ashes 2015: Nice guy Steven Finn is making up for lost time – and quickly

Nice guy Finn is making up for lost time – and quickly

He was man-of-the-match in the third Test following his recall to the England side
Ashes 2015: Remember Ashton Agar? The No 11 that nearly toppled England

Remember Ashton Agar?

The No 11 that nearly toppled England
Turkey-Kurdish conflict: Obama's deal with Ankara is a betrayal of Syrian Kurds and may not even weaken Isis

US betrayal of old ally brings limited reward

Since the accord, the Turks have only waged war on Kurds while no US bomber has used Incirlik airbase, says Patrick Cockburn
VIPs gather for opening of second Suez Canal - but doubts linger over security

'A gift from Egypt to the rest of the world'

VIPs gather for opening of second Suez Canal - but is it really needed?
Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

Fashion editor, Alexander Fury, applauds a man who clearly has more important things on his mind
The male menopause and intimations of mortality

Aches, pains and an inkling of mortality

So the male menopause is real, they say, but what would the Victorians, 'old' at 30, think of that, asks DJ Taylor
Man Booker Prize 2015: Anna Smaill - How can I possibly be on the list with these writers I have idolised?

'How can I possibly be on the list with these writers I have idolised?'

Man Booker Prize nominee Anna Smaill on the rise of Kiwi lit
Bettany Hughes interview: The historian on how Socrates would have solved Greece's problems

Bettany Hughes interview

The historian on how Socrates would have solved Greece's problems
Art of the state: Pyongyang propaganda posters to be exhibited in China

Art of the state

Pyongyang propaganda posters to be exhibited in China
Mildreds and Vanilla Black have given vegetarian food a makeover in new cookbooks

Vegetarian food gets a makeover

Long-time vegetarian Holly Williams tries to recreate some of the inventive recipes in Mildreds and Vanilla Black's new cookbooks